Loading insider details...
Latest Form 4 (Oct 20, 2026): Tax Withholding of 597 MNPR shares, $55.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 20, 2026 | Monopar Therapeutics (MNPR) | Tax Withholding | 597 | $55.3K |
| Oct 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 9,801 | n/a |
| Sep 29, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 14,056 | $421.7K |
| Jul 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 12,873 | n/a |
| Apr 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 6,732 | n/a |
| Jan 30, 2026 | Monopar Therapeutics (MNPR) | Other (see footnotes) | 62,815 | n/a |
| Jan 5, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 8,724 | n/a |
| Dec 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 16,753 | n/a |
| Oct 2, 2025 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 8,726 | n/a |
| Sep 26, 2025 | Monopar Therapeutics (MNPR) | Sale | 550,229 | $35.00M |